论文部分内容阅读
目的探讨复发性卵巢癌再次行肿瘤细胞减灭术的临床效果。方法对我院及北京大学肿瘤医院1990年1月至2004年2月收治的68例复发性卵巢癌再次手术患者的临床资料进行回顾性分析。结果68例再次手术中,无肉眼残留26例,残留<2cm者18例,残留>2cm者24例,带瘤生存10例,无瘤生存11例,死亡47例。中位生存期手术组与非手术组无显著性差异。结论对于复发性卵巢癌,有条件者应选择再次手术,可以改善患者的一般状况,提高生活质量。
Objective To investigate the clinical effect of cytoreductive surgery in recurrent ovarian cancer. Methods The clinical data of 68 patients with recurrent ovarian cancer who underwent reoperation in our hospital and Peking University Cancer Hospital from January 1990 to February 2004 were analyzed retrospectively. Results In the 68 cases undergoing reoperation, there was no macroscopic residue in 26 cases, residual <2cm in 18 cases and residual> 2cm in 24 cases. There were 10 cases with tumor, 11 cases without tumor and 47 cases died. There was no significant difference in median survival between surgical and non-surgical groups. Conclusion For recurrent ovarian cancer, patients with conditions should choose to re-surgery, can improve the general condition of patients and improve the quality of life.